OKYO Pharma Ltd (OKYO) stock

OKYONasdaqBiological Products, (No Diagnostic Substances)

Financials through fiscal 2026, year ended Mar 31, 2026Last filing: 20-F on Jul 20, 2026Score 1/30

$1.40−0.02 (-1.41%)

Close on Nov 12, 2026Market cap $73.47MP/E –Yield –

OKYO Pharma ebitda

EBITDA is earnings before interest, taxes, depreciation and amortization, a rough measure of cash profit from operations.

OKYO Pharma has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.

See a number that looks wrong?